Sreenivasa Ramaiahgari

A 3D in vitro model of differentiated HepG2 cell spheroids with improved liver-like properties for repeated dose high-throughput toxicity studies

Sreenivasa Ramaiahgari, Michiel W. den Braver, Bram Herpers et al. · Archives of Toxicology · 2014 · 358 citations

Pharmacy, Pharmacology, Toxicology +13

Elevated insulin-like growth factor 1 receptor signaling induces antiestrogen resistance through the MAPK/ERK and PI3K/Akt signaling routes

Yinghui Zhang, Marja Moerkens, Sreenivasa Ramaiahgari et al. · Breast Cancer Research · 2011 · 171 citations · Full text

Medicine, Endocrinology, Oncology +16

From the Cover: Three-Dimensional (3D) HepaRG Spheroid Model With Physiologically Relevant Xenobiotic Metabolism Competence and Hepatocyte Functionality for Liver Toxicity Screening

Sreenivasa Ramaiahgari, Suramya Waidyanatha, Darlene Dixon et al. · Toxicological Sciences · 2017 · 139 citations · Full text

Pharmacy, Pharmacology, Toxicology +17

The Power of Resolution: Contextualized Understanding of Biological Responses to Liver Injury Chemicals Using High-throughput Transcriptomics and Benchmark Concentration Modeling

Sreenivasa Ramaiahgari, Scott S. Auerbach, Trey Saddler et al. · Toxicological Sciences · 2019 · 81 citations · Full text

Pharmacy, Pharmacology, Toxicology +17

Evaluation of 5-day In Vivo Rat Liver and Kidney With High-throughput Transcriptomics for Estimating Benchmark Doses of Apical Outcomes

William M. Gwinn, Scott S. Auerbach, Fred Parham et al. · Toxicological Sciences · 2020 · 80 citations · Full text

Pharmacy, Toxicology, Hepatotoxicology +15